PATENT CLAIM ANALYSIS

Application Number: 16039877
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "219000"]

Abstract:
Provided herein are substituted fused quadracyclic compounds useful as inhibitors of MK2. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted fused quadracyclic compounds.

Claim (Index 49):
The method of  claim 48 , wherein the diabetes is Type I, Type II, or gestational diabetes.

Metadata:
- Claim Count in Document: 110.0
- Percentile: 95.0
- Lexical Diversity: 1.65217
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15397212', '13249166', '14448160', '12598882', '14728562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7665734005638417
- 35 USC 102 Novelty (BERT): 0.5538601056061982
- Combined Prediction Score: 0.7453020710680774
- Mean Citation Score: 328.424554
- Max Citation Score: 461.9091
- Similarity Product: 232.15565788325068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test